Cipher Capital’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,935
Closed -$414K 464
2022
Q2
$414K Buy
+1,935
New +$473K 0.09% 257
2016
Q2
Sell
-18,326
Closed -$1.39M 707
2016
Q1
$1.39M Buy
+18,326
New +$1.36M 0.13% 273

Other funds holding CRL

Cipher Capital's CRL Position: Q3 2022 in Review

Cipher Capital sold out of Charles River Laboratories (CRL) in Q3 2022, closing a stake of 1,935 shares — an estimated $414K sold.

Cipher Capital first reported a position in CRL in Q1 2016 and held it in 2 quarters. The position peaked at $1.39M in Q1 2016. 583 funds tracked by Wall St. Rank hold CRL as of Q3 2022.

  • Cipher Capital reported no remaining Charles River Laboratories position as of Q3 2022 after selling out during the quarter.
  • Cipher Capital sold 1,935 Charles River Laboratories shares in Q3 2022, an estimated $414K.
  • Cipher Capital first reported a position in Charles River Laboratories in Q1 2016 and held it in 2 quarters.
  • Cipher Capital's Charles River Laboratories position peaked at $1.39M in Q1 2016.
  • 583 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2022.

Based on Cipher Capital's 13F filing for Q3 2022, filed 14 Nov 2022.